Concord Medical Files 6-K Report

Ticker: CCM · Form: 6-K · Filed: Sep 30, 2025 · CIK: 1472072

Concord Medical Services Holdings Ltd 6-K Filing Summary
FieldDetail
CompanyConcord Medical Services Holdings Ltd (CCM)
Form Type6-K
Filed DateSep 30, 2025
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, regulatory-filing

TL;DR

Concord Medical (CCM) filed its monthly 6-K report on 9/30/25, standard foreign issuer update.

AI Summary

Concord Medical Services Holdings Limited filed a Form 6-K on September 30, 2025, reporting for the month of September 2025. The filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company's principal executive office is located in Beijing, People's Republic of China.

Why It Matters

This filing indicates ongoing reporting compliance for Concord Medical Services Holdings Limited, a foreign private issuer, which is important for investors tracking the company's regulatory disclosures.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational updates that would indicate a change in risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is required to make public pursuant to the laws of its home country or that it has filed or will file with a stock exchange.

What is the filing date and reporting period for this 6-K?

This Form 6-K was filed as of September 30, 2025, and reports for the month of September 2025.

Where is Concord Medical Services Holdings Limited's principal executive office located?

The principal executive office of Concord Medical Services Holdings Limited is located at Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020, People's Republic of China.

Does Concord Medical Services Holdings Limited file annual reports under Form 20-F or 40-F?

Concord Medical Services Holdings Limited indicates it files annual reports under cover of Form 20-F.

What is the Commission File Number for Concord Medical Services Holdings Limited?

The Commission File Number for Concord Medical Services Holdings Limited is 001-34563.

Filing Stats: 254 words · 1 min read · ~1 pages · Grade level 14.2 · Accepted 2025-09-30 06:02:41

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-34563 CONCORD MEDICAL SERVICES HOLDINGS LIMITED Room A1-A5 26/F, East Zone, Hanwei Plaza No. 7 Guanghua Road, Chaoyang District, Beijing 100020 People’s Republic of China (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F x Form 40-F ¨ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨ Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨ Resignation of Director On September 28, 2025, Mr. Yue Yu submitted his resignation as Director of Concord Medical Services Holdings Limited (the “Company”), effective on September 29, 2025. The resignation of Mr. Yu was due to personal reasons and was not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CONCORD MEDICAL SERVICES HOLDINGS LIMITED By: /s/ Jianyu Yang Name: Jianyu Yang Title: Chairman and Chief Executive Officer Date: September 30, 2025

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing